Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
ALNY Key Statistics
Stock Snapshot
The current Alnylam Pharmaceuticals(ALNY) stock price is $397.55, with a market capitalization of 53.59B. The stock trades at a price-to-earnings (P/E) ratio of 1653.70.
During the trading session on 2025-12-14, Alnylam Pharmaceuticals(ALNY) shares reached a daily high of $411.01 and a low of $387.03. At a current price of $397.55, the stock is +2.7% higher than the low and still -3.3% under the high.
Trading volume for Alnylam Pharmaceuticals(ALNY) stock has reached 1.61M, versus its average volume of 1.31M.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
Over the past 52 weeks, Alnylam Pharmaceuticals(ALNY) stock has traded between a high of $495.55 and a low of $205.87.
ALNY News
Alnylam Pharma, the Healthcare sector company, was revisited by a Wall Street analyst on December 12. Analyst Michael Ulz from Morgan Stanley maintained a Hold...
Alnylam Pharmaceuticals (ALNY) just hit a fresh milestone, landing a spot in the Nasdaq 100 while simultaneously moving to repurchase a slice of its 2027 conver...
Alnylam Pharmaceuticals (ALNY) said it reached privately negotiated agreements to repurchase for cash about $34.4M of its 1.00% Convertible Senior Notes due 202...
Analyst ratings
68%
of 31 ratingsMore ALNY News
TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRank...
Stifel raised the firm’s price target on Alnylam (ALNY) to $508 from $495 and keeps a Buy rating on the shares. The firm “refreshed diligence” on many companies...
Below is Validea's guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY). Of the 22 guru strategies we follow, ALNY rates highest using our Twin Mome...
